July 7, 2022


Its all about the Health

That Pricey New Alzheimer’s Drug? Still Not Great

1 min read

We really need good treatments for Alzheimer’s. But Biogen’s very expensive and maybe not that effective drug Aduhelm is not the treatment we’re looking for. Today we look at the saga of Adulhelm’s approval and it’s road to acceptance (or lack thereof) in the medical community.

Related HCT episodes:
How Accurate are EPA Air Pollution Data? https://youtu.be/PM-ZiyuTsrI
Aduhelm’s Unusual FDA Approval Saga: https://youtu.be/URiB0lbdFwU

Be sure to check out our podcast!

Other Healthcare Triage Links:
1. Support the channel on Patreon: http://vid.io/xqXr
2. Check out our Facebook page: http://goo.gl/LnOq5z
3. We still have merchandise available at http://www.hctmerch.com
4. Aaron’s book "The Bad Food Bible: How and Why to Eat Sinfully" is available wherever books are sold, such as Amazon: http://amzn.to/2hGvhKw

Aaron Carroll — Writer
Meredith Danko – Social Media
Tiffany Doherty — Writer and Script Editor
John Green — Executive Producer
Stan Muller — Director, Producer
Mark Olsen – Art Director, Producer

News Source: Healthcare Triage

All Rights Reserved © ACN 2020

ACN Privacy Policies
Area Control Network (ACN)
Area Control Network
Area Control Network Center